SUZHOU HIGHFINE BIOTECH CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 48.21 CNY | -3.81% |
|
-11.54% | -19.66% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 672M 93.03M | Sales 2025 * | 888M 123M | Capitalization | 5.21B 721M |
|---|---|---|---|---|---|
| Net income 2024 * | 194M 26.88M | Net income 2025 * | 257M 35.6M | EV / Sales 2024 * | 7.75 x |
| Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 5.86 x |
| P/E ratio 2024 * |
26.8
x | P/E ratio 2025 * |
20.3
x | Employees | - |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 26.27% |
More Fundamentals
* Assessed data
More news
| 1 day | -3.81% | ||
| 1 week | -11.54% | ||
| Current month | +10.30% | ||
| 1 month | +22.11% | ||
| 3 months | +14.57% | ||
| 6 months | -36.71% | ||
| Current year | -19.66% |
1 week
47.77
56.08
1 month
37.2958.22
Current year
36.5160.88
1 year
36.51118.88
3 years
36.51118.88
5 years
36.51118.88
10 years
36.51118.88
| Managers | Title | Age | Since |
|---|---|---|---|
Yong Zhu
CEO | Chief Executive Officer | 53 | 03-12-01 |
Xiao Yan Wang
DFI | Director of Finance/CFO | 44 | 04-01-31 |
Hao Yi Sun
CHM | Chairman | 46 | 11-06-30 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Qing Wang
BRD | Director/Board Member | 58 | 21-05-31 |
Yong Zhu
CEO | Chief Executive Officer | 53 | 03-12-01 |
Jie Xu
BRD | Director/Board Member | 45 | 04-10-31 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-15 | 48.21 | -3.81% | 3,378,780 |
| 24-05-14 | 50.12 | -2.66% | 2,851,854 |
| 24-05-13 | 51.49 | -5.38% | 4,006,868 |
| 24-05-10 | 54.42 | +1.00% | 5,265,060 |
| 24-05-09 | 53.88 | -1.14% | 6,595,095 |
End-of-day quote Shenzhen S.E., May 14, 2024
More quotes
Suzhou Highfine Biotech Co Ltd is a China-based company mainly engaged in the research and development (R&D), production and sales of Peptide synthesis reagents. The Company's main products include Peptide synthesis reagents such as condensation reagents, protection reagents and chiral racemic inhibition reagents, general-purpose molecular blocks and protein reagents.
Sector
Commodity Chemicals
Calendar
2024-08-15
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
48.21
Average target price
-
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -19.66% | 748M | |
| +6.11% | 105B | |
| -4.67% | 63.83B | |
| +73.81% | 45.28B | |
| +15.46% | 38.93B | |
| +5.46% | 33.06B | |
| +11.59% | 20.21B | |
| +13.74% | 16.94B | |
| +20.05% | 16.08B | |
| +5.02% | 14.49B |
- Stock Market
- Equities
- 301393 Stock